Letters High reprint orders

Time to open up the finances of medical journals

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e4968 (Published 23 July 2012) Cite this as: BMJ 2012;345:e4968
  1. Richard Smith, chair1
  1. 1Patients Know Best, London SW4 0LD, UK
  1. richardswsmith{at}yahoo.co.uk

Perhaps the most striking thing about this paper is that the American publishers—all doctors’ organisations—refused to provide data. Inevitably, readers will wonder what they are hiding.1 The answer, I suspect, is the massive profits that they make from selling reprints of research funded by drug companies.

Around a half of drug sales are in North America, and reprints are …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe